Tipranavir and Ritonavir vs. Saquinavir and Ritonavir Used With Two Nucleoside Reverse Transcriptase Inhibitors in Single Protease Inhibitor-experienced HIV-1 Patients

NCT02239835 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

79

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Tipranavir (TPV) low dose
DRUG: Tipranavir (TPV) high dose
DRUG: Ritonavir low dose
DRUG: Ritonavir high dose
DRUG: Saquinavir

Sponsor

Boehringer Ingelheim